Redeye: Xspray Pharma - Inflection point nearing

Report this content

We reiterate our positive stance on Xspray Pharma; +100% potential upside in our Base Case.

Read more and download the research update:

Start following Xspray Pharma at Redeye to instantly receive our latest analyst updates and comments.

This is a press release from Redeye - Research Powered Investment Banking.